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Abstract
Context: There is considerable concern about the spread of HIV disease among Aboriginal
peoples in British Columbia.
Objective: To estimate the number of Aboriginal British Columbians infected with HIV.
Design and setting: A population-based analysis of Aboriginal men and women in British
Columbia, Canada from 1980 to 2001.
Participants: Epidemic curves were fit for gay and bisexual men, injection drug users, men and
women aged 15 to 49 years and persons over 50 years of age.
Main outcome measures: HIV prevalence for the total Aboriginal population was modeled using
the UNAIDS/WHO Estimation and Projection Package (EPP). Monte Carlo simulation was used to
estimate potential number infected for select transmission group in 2001.
Results: A total of 170,025 Aboriginals resided in British Columbia in 2001, of whom 69% were
15 years and older. Of these 1,691 (range 1,479 – 1,955) men and women aged 15 years and over
were living with HIV with overall prevalence ranging from 1.26% to 1.66%. The majority of the
persons infected were men. Injection drug users (range 1,202 – 1,744) and gay and bisexual men
(range 145, 232) contributed the greatest number of infections. Few persons infected were from
low risk populations.
Conclusion: More than 1 in every 100 Aboriginals aged 15 years and over was living with HIV in
2001. Culturally appropriate approaches are needed to tailor effective HIV interventions to this
community.
Introduction
Aboriginal peoples have resided in British Columbia since
the end of the last ice age 12,000 years ago [1]. Archaeo-
logical evidence suggests that these first peoples arrived
here through successive migrations across a land bridge
spanning the Bering Strait and then arrived here either
along the coast [2] or through an interior passage left as
the glacier sheets melted [3]. Three distinct cultural areas
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with many distinct cultures are prominent – the subartic
in the Northeast, the plateau in the Southeast, and the
Northwest Coast along the coast from the Queen Char-
lottes to the southern most tip of Vancouver Island. Prior
to contact with Europeans, populations were quite large
especially along the coast.
Contact with Europeans brought numerous infectious dis-
eases that reduced the Aboriginal population in British
Columbia by nearly two thirds. The total population con-
tinued to decrease until the 1920s and have since
rebounded to sizes near pre-contact levels [4,5]. However,
high levels of mortality persisted long after European con-
tact, mainly due to infectious diseases [4,6]. Initially, dis-
ease like smallpox had a devastating affect on population
size [4]. Later, Aboriginals where inflicted with diseases
like tuberculosis that were endemic until quite recently
[7]. In recent years, there has been increasing concern
regarding the spread of HIV disease among Aboriginal
peoples. HIV appears to be concentrated among injection
drug users and gay and bisexual men [8-11]. Rates of HIV
infection among pregnant women remain low, but are sig-
nificantly higher than in the general population[12]. The
purpose of this paper is to estimate the current number of
Aboriginal British Columbians infected with HIV.
Methods
Our estimates of HIV prevalence in the British Columbian
Aboriginal population were based upon surveillance data.
Aboriginals refer to persons who self-identify as – North
American Indians, Métis, and Inuit. Also included are
those that did not self-identify as Aboriginal, but who
were registered under the Indian Act and/or were mem-
bers of a band or First Nation [13].
HIV prevalence data from at risk populations were used to
model HIV prevalence trends for adults and to calculate
the number of new infections, AIDS cases and deaths
from 1980 to 2001. Six adult Aboriginal population
groups, aged 15 years and over, were modeled – gay and
bisexual men, injection drug users in Greater Vancouver
and the rest of the province, low-risk men and women
aged 15 to 49 years, and low-risk persons aged 50 years
and over. Low-risk refers to Aboriginal persons who based
on current seroprevalence studies were less likely to
acquire HIV than gay and bisexual men and injection drug
users in this population. Gay and bisexual men were esti-
mated to be 3% of the total Aboriginal male population
[14]. The total injection drug user population in Greater
Vancouver was based on capture-recapture estimates and
for the rest of the province on estimates of clean needle
distributed at needle exchanges and proportion of drug
over deaths [15,16]. Based on estimates derived from the
Vancouver Injection Drug Users Study (VIDUS) at least
quarter of these injection drug users are of Aboriginal
descent [8]. The population of injection drug users in the
Greater Vancouver region was estimated to be 12,000
(95% CI: 10,000 – 15,000) and of similar magnitude out-
side the region as half the needles distributed at needle
exchanges and overdose deaths occur outside of Greater
Table 1: Input assumptions for total population and HIV prevalence for Aboriginal persons ages 15 and over, by scenario and group
Category/ years Gay and 
Bisexual men
Injection drug users 15–49 years* 50+
Year Vancouver Other Men Women
Low growth scenario
Population
2001 1,600 3,000 3,000 39,400 46,700 24,100
HIV Prevalence
1 9 8 6 1 2 . 6 1 . 2 1 . 2000
1 9 9 1 1 4 . 3 1 . 7 1 . 7000
1996 15.0 6.0 2.0* 0 0 0
2001 19.0 38.0 2.0* 0 0 0
High growth scenario
Population
2001 1,600 4,250 3,250 38,700 45,900 24,100
HIV Prevalence
1 9 8 6 1 2 . 6 2 . 3 2 . 3000
1 9 9 1 1 4 . 3 1 . 7 1 . 7000
1996 15.0 6.0 6.0* 0 0 0
2001 19.0 38.0 6.0* .08 .10 0
* Values are assumed. Among 15 to 49 years olds posted rates are a third of published rates.Harm Reduction Journal 2005, 2:26 http://www.harmreductionjournal.com/content/2/1/26
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Vancouver[16]. In total, there were likely 24,000 injection
drug users in the province of which 6,000 were Aborigi-
nal. Population estimates for low-risk persons aged 15 to
49 years and those laged 50 years and over were based
intercensal estimates of Registered Indians produced by
BC Vital Statistics and adjusted to the 2001 Census popu-
lation of Aboriginals [16].
HIV prevalence estimates were obtained from a variety of
serosurveillance and cohort studies. Estimates of HIV
prevalence for the gay and bisexual men were obtained
from published and unpublished estimates from two
cohorts studies (Vancouver Lymphadenopathy AIDS
Study and the Vanguard Study) and adjusted to estimates
reported for the entire gay and bisexual male population
in Vancouver and British Columbia [12,17]. Among injec-
tion drug users HIV prevalence estimates were obtained
from published cohort and cross sectional studies. Annu-
alized estimates of HIV prevalence from 1996 onwards
were obtained from VIDUS[8,18]. Estimates prior to that
date were obtained from serosurveillance studies of street-
based populations and needle exchanges in Vancouver
and Victoria[12]. HIV prevalence estimates of low-risk
persons aged 15 to 49 years and 50 years and over were
based on data obtained from pregnant women and men
and women in alcohol rehabilitation[12,19,20].
Two scenarios were modelled based on varying assump-
tions relating to the size of the at-risk population and HIV
prevalence (refer to Table 1). The low growth scenario
assumed the at-risk gay and bisexual population to be 3%
of the adult male population. The population of Aborigi-
nal injection drug user in Greater Vancouver was assumed
to be 3,000 or 25% of injection drug users in that region,
the point estimate from the capture-recapture study[15].
Injection drug user population outside this region was
also assumed to be 3,000 since half of the overdose deaths
and clean needles distributed occur in this region. HIV
prevalence in gay and bisexual men was assumed to be
similar to the general gay and bisexual population. In
injection drug users HIV prevalence was assumed to
increase to 40% in Vancouver and to move-up to no more
than 2% in other areas of the province. HIV prevalence in
low-risk persons aged 15 to 49 years and 50 years and over
was assumed to be zero.
The high growth scenario assumed the gay and bisexual
male population to be the same as in the low growth sce-
nario. The Greater Vancouver Aboriginal injection drug
user population was assumed to be 3,750 persons or 25%
of the upper limit of the capture-recapture estimate of
15,000 [15]. A total of 500 Aboriginal injection drug users
in Victoria were assumed to have the same HIV prevalence
as in Greater Vancouver and added to the Greater Vancou-
ver group[21]. Among the remaining 3,250 injection drug
users from outside of Vancouver and Victoria, HIV preva-
lence was assumed to increase to 6% by 1996 [12]. HIV
prevalence in low-risk women aged 15 to 49 years was
assumed to increase to .08 by 2001 or a third of estimates
obtained from studies of pregnant women and women in
alcohol rehabilitation. HIV prevalence in low-risk men
aged 15–49 was also assumed to increase and the number
of HIV-infected persons aged 50 years and over was
assumed to be zero.
HIV prevalence for the total Aboriginal population was
modeled using the UNAIDS/WHO Estimation and Projec-
tion Package (EPP). In EPP, HIV prevalence time trends
were estimated by fitting a simple epidemiological model
to surveillance data[22]. Epidemic curves were fit for gay
and bisexual men, injection drug users, men and women
aged 15 to 49 years and persons over 65 years of age. Sep-
arate epidemic curves for these groups were then aggre-
gated by EPP to find the best fitting curve that describes
trends in HIV prevalence in the total adult Aboriginal over
time.
Monte Carlo simulation methodology was used to esti-
mate potential number infected for select transmission
group in 2001. Input parameters for the model were taken
from our low and high growth scenarios. The injection
drug user group was collapsed into one category for these
analyses. A total of 100,000 trials were completed to
derive potential ranges in the number of injection drug
users, gay and bisexual men, and low risk women in the
population.
Results
A total of 170,025 Aboriginals resided in the province in
2001, of whom 69% were 15 years and older. The major-
ity of Aboriginals were women (51%). The median age for
men and women was 26 and 28 years, respectively. North
American Indians made-up the largest component of the
population at 118,295 (70%), followed by Metis at
44,265 (26%), and Inuit at 800 (0.5%). The rest, 6660
(4%) were Aboriginals of other or multiple origin. The
Greater Vancouver population was 36,855 with 10,440
living in the city. The population was also highly mobile
with 46% of persons who were 5 years and older moving
at least once in the past five years.
Table 1 outlines the at-risk population and HIV preva-
lence assumptions for Scenarios one and two. As outlined
in this table the injection drug users and gay and bisexual
male populations are relatively small in comparison to
the low-risk populations aged 15 and over. In both scenar-
ios HIV prevalence is highest in Greater Vancouver injec-
tion drug users and second highest among gay and
bisexual men.Harm Reduction Journal 2005, 2:26 http://www.harmreductionjournal.com/content/2/1/26
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Figures 1 characterizes the trends in HIV prevalence in the
low and high growth scenarios since 1980. As note shown
here, HIV prevalence in the Aboriginal population has
increased notably since 1980.
Table 2 provides estimates of prevalence and the number
living with HIV by gender and transmission group in
2001. Estimates were derived from 100,000 Monte Carlo
simulation trials, where the input parameters were based
on the figures from the low and high growth scenarios
produced for this study. Based on this analysis, a total of
1,691 (range 1,479 – 1,955) men and women were living
with HIV at the end of 2001. Overall, 1.44% (range
1.26%, 1.66%) of the population 15 years and over was
HIV-positive. The majority of the persons infected were
men (55.3% ; range 55.6%, 54.8%). Injection drug users
(1,458; range 1,202 – 1,744) and gay and bisexual men
(186; range 145, 232) contributed the greatest number of
infections. Few of the persons living with HIV were from
low risk populations.
Discussion
More than 1 in every 100 Aboriginal persons aged 15 years
and over was living with HIV in 2001. Approximately a
quarter to a third of all infections among Aboriginal peo-
ples in Canada occurred in this province [23]. The rate of
infection among Aboriginal British Columbians was
approximately two times the rate for Canadian Aborigi-
nals overall. The majority of new infections among Abo-
riginals occurred in injection drug users with the majority
of these being concentrated in Greater Vancouver. How-
ever, our results point to increasing numbers of injection
drug users being infected outside Greater Vancouver and
considerable number of Aboriginal gay and bisexual men
infected with HIV in this province.
The high prevalence of HIV occurring among British
Columbian Aboriginals was mainly due to increases in
new infections among injection drug users. In Vancouver,
HIV prevalence among Aboriginal injection drug users has
increased from less than 5% in early 1990s to approxi-
mately 40% in 2004 [24]. The prevalence of HIV among
Aboriginal injection drug users was considerably higher
than their non-Aboriginal counterparts; and half of the
Aboriginal drug user population were women, which was
a considerably higher proportion than in the non-Aborig-
inal population [8]. Risk factors for HIV acquisition
appear to vary by gender as well. Among women, frequent
speedball (combined cocaine and heroin) injection and
going on binges of injection drug use were independent
predictors of HIV seroconversion; while among men HIV
seroconversion was associated with frequent speedball
injection and cocaine injection [8,18]
The acquisition of HIV among Aboriginals was partially
due to syringe sharing. Needle exchanges in British
Columbia provide needles, needle cleaning supplies and
condoms to injection drug users and sex trade workers.
Although six millions needles are given out annually
through this program, needle exchanges provide sterile
equipment for only a small percentage of drug injection
episodes – in Vancouver this was estimated to be as low as
10 to 20% [25]. Among injection drug users daily needle
exchanges remains modest at approximately 40% at fixed
sites and 50% at mobile sites [26]. Even with daily
exchange approximately a third of participants were bor-
rowing and lending needles. Although acquiring needles
exclusively from the needle exchange attendance was
independently associated with less sharing, persistent
sharing was associated with difficulty accessing sterile nee-
dles, bingeing, and frequent cocaine injection [27].
Unprotected sex also played a role in the acquisition of
new infections. There was considerable variability among
injection drug users in condom use with sex trade clients
and casual and regular sexual partners [8,18,28]. Based on
VIDUS data the vast majority of men and women were
sexually active, 72 and 92% respectively in the last six
months prior to enrolment. The mean age of first sexual
encounter was 15 years for either gender. Life time
number of sexual partners was also high with over 20% of
men and 50% of women having more than 100 sexual
partners. Among men and women, condoms were gener-
ally not used with regular partners, half the time with cas-
ual partners, and 80% of the time with clients. Nine per
cent of men reported having had sex with a man with con-
dom use being 71% for anal intercourse and 60% for oral
sex with clients. Among women sex trade workers vaginal
intercourse was most common with condom usage being
82%. Seventy-five percent of these women used condoms
during oral sex with clients. Aboriginal generally exhibit
the same pattern of condom usage as non-Aboriginal per-
sons in this cohort.
HIV prevalence among Aboriginal British Columbians by sce- nario, 1980 to 2001 Figure 1
HIV prevalence among Aboriginal British Columbians by sce-
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Our results point to a number of important policy impli-
cations and gaps in knowledge. If our estimates of injec-
tion drug users are correct then a considerable number of
injection drug users are living outside of Greater Vancou-
ver and likely do not have the same access to harm reduc-
tion services or have to travel further to get to them.
Persons outside of Vancouver and Victoria are known to
have limited access to drug rehabilitation program or to
methadone. The effectiveness of needle exchanges in
places like Campbell River, Chilliwack, Gibsons, Kam-
loops, Kelowna, Nanaimo, Powell River, Prince George,
Prince Rupert, Quesnel, Surrey, and Veron is also not well
characterized. Little is known about HIV prevalence of
injection drug users at these sites, and whether reported
rates are higher as or much lower than those observed in
Vancouver and Victoria.
Although the population of Aboriginal gay and bisexual
men is small it still accounts for a large proportion of HIV
infections. Little is known about how much of male to
male sexual activity is attributed to sex work. Future pre-
vention work in this community needs to be targeted,
even though these men are more likely to be more mar-
ginalized and in the sex trade than their non-Aboriginal
gay and bisexual counterparts[9].
Finally, the spread of HIV to the general Aboriginal popu-
lation is not well characterized. There is no conclusive evi-
dence to suggestion that the increase in seroprevalence
among pregnant women and low risk men is not directly
attributable to injection drug use. We need to ensure that
all Aboriginal pregnant women have access to HIV testing
and to antenatal care. Currently, few Aboriginal women
who have HIV-positive children are able to seek adequate
care for themselves or their children[20]. Access to antiret-
roviral therapy among those infected needs to be
improved. Aboriginal British Columbians are also not
accessing treatment at the same rate as non-Aborigi-
nals[29]. Differences in access are likely attributed to dif-
ferences in living conditions, access to physicians, as well
as the remoteness of some communities.
In conclusion, more than 1 in every 100 adults aged 15
years and over was living with HIV in 2001. The rate of
infection observed in this study was greatly affected by the
size of the injection drug user population and the spread
of HIV into the general population. Governments and
non-government organizations need to work together to
ensure the funding of culturally appropriate HIV preven-
tion programs.
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